Ah shoot. PDEX numbers not sustainable at all. 10Q reveals that backlog dropped sequentially from $14.2M down to $10.6M. And sounds like $660K of the revenue this quarter was non-recurring. Will flip my shares on the pop tomorrow.
From the 10Q:
During the second quarter of fiscal 2016 we completed the development of another cranial driver to meet the specifications of another medical device customer and we were able to recognize non-recurring engineering revenue, much of which had been previously deferred, in the amount of $660,000, and shipped approximately $550,000 of the newly developed product to this customer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.